Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Discover which cash back credit card offers the best rates in 2023. Compare options to find the card that maximizes your benefits.
27,149 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Amazon launches a $200 billion AI-focused capex plan for 2026, with Trainium and Anthropic in the mix. Here’s what in...
Hut 8 is pivoting to AI data center infrastructure, prompting a Canaccord upgrade that nearly doubles the firm’s pric...
Global events, gas prices, and energy markets can influence your 2027 Social Security rise. This guide breaks down th...
Investors react to a key vote in the semiconductor space as IonQ jumps on the SkyWater deal. Here’s what it means for...
A surge in Lemonade's stock grabbed attention as investors weighed renewed reinsurance terms and AI-driven growth. Th...
Oracle has shifted from a steady performer to a stock many traders watch for AI-driven momentum. This guide breaks do...
Can one stock turn you into a millionaire? This guide examines Micron stock, the real-world math of wealth, and smart...
SoundHound AI aims to own the voice layer that connects users to services. This article builds a practical bull case ...
The Trump administration announced a historic draw from the Strategic Petroleum Reserve to ease gasoline prices, with...
Bitcoin stands at a critical crossroads, pulled by a $177 leveraged ETF surge but tested by rising inflation and loom...
A renewed clash over listing distribution between Zillow, Compass, and MRED has sparked debate among brokers and lend...